The integrity of the blood-brain barrier in Alzheimer's disease

被引:57
|
作者
Algotsson, A. [1 ]
Winblad, B. [1 ]
机构
[1] Karolinska Univ Hosp, Karolinska Inst, Div Clin Geriatr, Dept Neurobiol Caring Sci & Soc, SE-14186 Huddinge, Sweden
来源
ACTA NEUROLOGICA SCANDINAVICA | 2007年 / 115卷 / 06期
关键词
Alzheimer's disease; blood-brain barrier; gender; plasma creatinine;
D O I
10.1111/j.1600-0404.2007.00823.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective - To evaluate the integrity of the blood-brain barrier (BBB) in incident Alzheimer's disease (AD). Materials and methods - The mean age of the 157 patients (45% men) was 69.7(9.4) years (range 51-88 years). The patients had undergone a thorough investigation including magnetic resonance imaging or computed tomography of the brain. The cerebrospinal(CSF)/plasma albumin ratio (albumin ratio) was used as a measure of BBB function. Results - There were gender differences with respect to albumin ratio and plasma creatinine with higher values in men (P < 0.001). 42% of the men and 13% of the women (P < 0.001) had a mild to moderate BBB dysfunction when applying the reference limit of the laboratory ( < 9.2). Both male gender (P = 0.002) and plasma creatinine (P = 0.009) were independently associated with the albumin ratio when controlling for putative confounders. Conclusions - The BBB is dysfunctional in a portion of patients with AD, both women and, primarily, men. The dysfunction might influence the clearance of both harmful and beneficial substances across the barrier. Renal function might have an impact on the BBB.
引用
收藏
页码:403 / 408
页数:6
相关论文
共 50 条
  • [21] Transport of drugs across the blood-brain barrier in Alzheimer's disease
    Nicolazzo, Joseph A.
    Mehta, Dharmini C.
    THERAPEUTIC DELIVERY, 2010, 1 (04) : 595 - 611
  • [22] Dyslipidemia in Alzheimer's Disease Is Associated with Blood-Brain Barrier Impairment
    Bowman, Gene L.
    Kaye, Jeffery A.
    Quinn, Joseph F.
    NEUROLOGY, 2010, 74 (09) : A137 - A137
  • [23] Ultrasound Blood-Brain Barrier Opening and Aducanumab in Alzheimer's Disease
    Rezai, Ali R.
    D'Haese, Pierre-Francois
    Finomore, Victor
    Carpenter, Jeffrey
    Ranjan, Manish
    Wilhelmsen, Kirk
    Mehta, Rashi I.
    Wang, Peng
    Najib, Umer
    Teixeira, Camila Vieira Ligo
    Arsiwala, Tasneem
    Tarabishy, Abdul
    Tirumalai, Padmashree
    Claassen, Daniel O.
    Hodder, Sally
    Haut, Marc W.
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 390 (01): : 55 - 62
  • [24] Microvascular injury and blood-brain barrier leakage in Alzheimer's disease
    Zipser, B. D.
    Johanson, C. E.
    Gonzalez, L.
    Berzin, T. M.
    Tavares, R.
    Hulette, C. M.
    Vitek, M. P.
    Hovanesian, V.
    Stopa, E. G.
    NEUROBIOLOGY OF AGING, 2007, 28 (07) : 977 - 986
  • [25] Treatment of Alzheimer's Disease and Blood-Brain Barrier Drug Delivery
    Pardridge, William M.
    PHARMACEUTICALS, 2020, 13 (11) : 1 - 25
  • [26] Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease
    Bell, Robert D.
    Zlokovic, Berislav V.
    ACTA NEUROPATHOLOGICA, 2009, 118 (01) : 103 - 113
  • [27] Alzheimer's disease: future drug development and the blood-brain barrier
    Pardridge, William M.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2019, 28 (07) : 569 - 572
  • [28] Amyloid-β Peptides, Alzheimer's Disease and the Blood-brain Barrier
    Gosselet, Fabien
    Saint-Pol, Julien
    Candela, Pietra
    Fenart, Laurence
    CURRENT ALZHEIMER RESEARCH, 2013, 10 (10) : 1015 - 1033
  • [29] Blood-brain barrier dysfunction as a cause and consequence of Alzheimer's disease
    Erickson, Michelle A.
    Banks, William A.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2013, 33 (10): : 1500 - 1513
  • [30] Imaging blood-brain barrier disruption in neuroinflammation and Alzheimer's disease
    Lee, Rae-Ling
    Funk, Kristen E.
    FRONTIERS IN AGING NEUROSCIENCE, 2023, 15